UN Access to Medicines Panel Undermines Bayh-Dole
We cannot know what biological killer will next emerge, when it will be born and where globalization’s winds will take it. But we do know that choking-off future private investment in future healthcare...
View ArticleNIH Director Collins Stands Up to the March in Mob
The problem with this theory is that the Bayh-Dole Act does not provide agencies the authority to regulate product prices. The law allows universities and contractors to own inventions made with...
View ArticleProperty Rights Key to Bayh-Dole Act’s Success
The focus of the political advocates pushing march-in may be lower drug costs. But the long-term costs of ripping apart IP rights are far higher and more fundamental than advocates acknowledge. The...
View ArticleWinning the Drug Development Debate
We create two new companies around academic inventions every day of the year. The critical role such companies play in drug development is clear. The successful integration of public research...
View ArticleMake American Innovation Great Again
It's a fundamental principal of economics that the secure ownership of personal property is essential for prosperity. Walk through any public park and see how seldomly people bother to pick up trash...
View ArticleCommercialization of University Research Threatened by Proposed State...
EFF’s Reclaim Invention Act, Draft Model Statute may seem an odd approach to folks in DC but when lined up with a state-level lobby of IP-uninformed and angry local businesses lobby, state legislators...
View ArticleAdvice for the Trump Administration and New Congress: Protect Bayh-Dole and...
Bayh-Dole is running on autopilot without Executive branch oversight and U.S. patents are no longer the world's gold standard. Without a course correction, we could be headed back to the bad old...
View ArticleThe National Cancer Institute Didn’t Deserve This Treatment From the New York...
While those in the military are often thanked for their service, let's also thank researchers like Dr. Rosenberg and his colleagues who spend their lives trying to alleviate human suffering. But that...
View ArticleEarly Stage Innovation’s Chance to Save Itself
Universities in particular must explain to their congressional delegations why R&D must continue to be funded and why its Bayh-Dole based commercialization bridge must be protected so federal funds...
View ArticleWant to Revive the Economy? Restore the Patent System!
The old arguments that patents inhibit innovation, and non-exclusivity with compulsory licensing leads to a brave new world are now in vogue. We've stood at this fork in the road before. It requires...
View ArticleAcademic Patent Licensing Helps Drive the U.S. Economy
What's even more impressive is the impacts on gross industry output and GDP are up 14% while the number of U.S. jobs supported rose 12% since the previous report issued two years ago. That's...
View ArticleProposal from Senator King Won’t Reduce Drug Prices, Just Innovation
Many were stunned to learn that Senator Angus King (I-ME) included language undermining the Bayh-Dole Act in the report of the Senate Armed Services Committee as it approved the National Defense...
View ArticleBernie Sander’s Really Bad Idea
Sen. Bernie Sanders (I-VT) introduced legislation requiring every agency and non-profit entity to include a "reasonable pricing" provision based on King's formula for any life science invention made...
View ArticleConservatives’ Letter to U.S. Senate Says Preserve Bayh-Dole
Though aimed at certain pharmaceutical products, Sens. Angus King’s and Bernie Sanders’ potential amendments would throw the key to the Bayh-Dole Act’s success —certainty and exclusivity of the...
View ArticleThink Twice Before Pulling the Plug on Tech Transfer
Most assaults on public/private sector R&D partnerships are launched by those who believe patents are inherently bad and that through some undefined magic publicly funded inventions will be...
View ArticlePity the Patients if Exclusive Licensing is Undermined
We've learned from experience that just because a theory's off base doesn't mean it won't take root, particularly when it involves patents and medicine. "No Vaccines Before the Next Zika Outbreak?: A...
View ArticleWhen Big Brother Comes Marching In: Patent Challenges on Entrepreneurial...
Bayh-Dole has recently come under attack, as some are trying to highjack certain provisions to be used as a cost control measure for novel therapeutics as the cost of drugs skyrocket. Should the...
View ArticleAnother IP Professor Attack On Patenting
I was just thinking how often someone teaching intellectual property law leads the attack on the patent system when "Racing for academic glory and patents: Lessons from CRISPR" appeared. It sounds a...
View ArticleAUTM Licensing Survey: Ominous trend likely attributable to eroding patent...
Concerns about the ability of academic institutions to keep contributing to the U.S. innovation economy go well beyond federal funding stagnation according to the recent AUTM survey. In an executive...
View ArticleCommerce Secretary ready to push update to tech transfer laws to ensure...
Secretary Ross gave an unequivocal endorsement of Bayh-Dole specifically, and more generally saying laws need to be updated to address business and technology realities of today, and to enable more...
View Article
